These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10518690)

  • 1. Study of Verapamil hydrochloride release from compressed hydrophilic Polyox-Wsr tablets.
    Dimitrov M; Lambov N
    Int J Pharm; 1999 Oct; 189(1):105-11. PubMed ID: 10518690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release from compressed hydrophilic POLYOX-WSR tablets.
    Kim CJ
    J Pharm Sci; 1995 Mar; 84(3):303-6. PubMed ID: 7616368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessibility of solid core tablet for dissolution in an asymmetric triple-layer matrix system.
    Yang L; Fassihi R
    J Pharm Pharmacol; 2003 Oct; 55(10):1331-7. PubMed ID: 14607013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.
    Wen H; Li X; Li Y; Wang H; Wang Y; Wang T; Pan W; Yang X
    Drug Dev Ind Pharm; 2018 Apr; 44(4):544-552. PubMed ID: 29130753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets.
    Kim CJ
    Drug Dev Ind Pharm; 1998 Jul; 24(7):645-51. PubMed ID: 9876509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets.
    Streubel A; Siepmann J; Dashevsky A; Bodmeier R
    J Control Release; 2000 Jun; 67(1):101-10. PubMed ID: 10773333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine hydrochloride controlled release POLYOX matrix tablets: screening of formulation variables using Plackett-Burman screening design.
    Jin SJ; Yoo YH; Kim MS; Kim JS; Park JS; Hwang SJ
    Arch Pharm Res; 2008 Mar; 31(3):399-405. PubMed ID: 18409056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silicone adhesive matrix of verapamil hydrochloride to provide pH-independent sustained release.
    Tolia G; Li SK
    AAPS PharmSciTech; 2014 Feb; 15(1):1-10. PubMed ID: 24022347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet.
    Timmins P; Delargy AM; Howard JR
    Pharm Dev Technol; 1997 Feb; 2(1):25-31. PubMed ID: 9552428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of controlled-release baclofen matrix tablets. II. Influence of some hydrophobic excipients on the release rate and in vitro evaluation.
    Abdelkader H; Youssef Abdalla O; Salem H
    AAPS PharmSciTech; 2008; 9(2):675-83. PubMed ID: 18500558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol.
    Varma M; Singla AK; Dhawan S
    Drug Dev Ind Pharm; 2004 May; 30(5):545-53. PubMed ID: 15244090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.
    Hong SI; Oh SY
    Int J Pharm; 2008 May; 356(1-2):121-9. PubMed ID: 18272308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
    Zhang F; Meng F; Wang ZY; Na W
    Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study.
    Maggi L; Segale L; Torre ML; Ochoa ME; Conte U
    Biomaterials; 2002 Feb; 23(4):1113-9. PubMed ID: 11791914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets.
    Li H; Hardy RJ; Gu X
    AAPS PharmSciTech; 2008; 9(2):437-43. PubMed ID: 18431663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpolymer Complexation Between Polyox and Carbopol, and Its Effect on Drug Release From Matrix Tablets.
    Zhang F; Lubach J; Na W; Momin S
    J Pharm Sci; 2016 Aug; 105(8):2386-96. PubMed ID: 27353208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.